Back to today’s briefing

Story perspectives

27 States Sue 23andMe Over Genetic Data Sales

6/10/2025

40 8

Summary

Story summary

Twenty-seven states and Washington, D.C. are taking a stand against 23andMe, filing a lawsuit to halt the sale of personal genetic data without consent. This legal action comes on the heels of 23andMe's bankruptcy and its proposed sale to Regeneron Pharmaceuticals. Attorneys general emphasize the sensitivity of genetic data, urging customers to safeguard their information by deleting it.

1 of 1

Story summary

Twenty-seven states and Washington, D.C. are taking a stand against 23andMe, filing a lawsuit to halt the sale of personal genetic data without consent. This legal action comes on the heels of 23andMe's bankruptcy and its proposed sale to Regeneron Pharmaceuticals. Attorneys general emphasize the sensitivity of genetic data, urging customers to safeguard their information by deleting it.